Rosenbaum David P. 4
4 · ARDELYX, INC. · Filed Feb 28, 2024
Insider Transaction Report
Form 4
ARDELYX, INC.ARDX
Rosenbaum David P.
SVP, Drug Development
Transactions
- Sale
Common Stock
2024-02-26$9.20/sh−5,183$47,684→ 175,936 total(indirect: By Spouse)
Holdings
- 378,985
Common Stock
- 77,592(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The shares are directly held by the Reporting Person's wife.
- [F2]The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.